Abstract
Vaccination against COVID–19 has made significant contribution in reducing the severity of the disease and the mortality worldwide. Although most of the vaccinations have been reported to be safe and without serious side effects other than mild to moderate pain at the vaccination site, occasional reports of developing overt viral disease after the vaccination have emerged. We report a case series of four cases, who developed symptomatic COVID–19 following vaccination. We describe the clinical features and intensive care management of these patients.
 Key words: COVID–19 infection; Vaccine; Critical care management; High flow nasal oxygen
 Citation: Huda AU, Mehboob A, Memon AS. Critical care management of COVID–19 infection in previously vaccinated patients – a case series. Anaesth. pain intensive care 2021;25(6):793–797;
 DOI: 10.35975/apic.v25i6.1711
 Received: September 08, 2021, Reviewed: September 19, 2021, Accepted: October 05, 2021
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.